|
Selected
publications
Tortora G, Caputo R, Damiano V, Caputo R, Troiani T,
Veneziani BM, De Placido S, Bianco AR, Zangemeister-Wittke
U, Ciardiello F. Combined targeted inhibition of BCL-2,
BCL-XL, epidermal growth factor receptor and protein
kinase A type I causes potent antitumor, apoptotic and
antiangiogenic activity. Clin Cancer Res 2003;9:866-71.
Bianco
C, Tortora G, Bianco R, Caputo R, Veneziani BM, Caputo
R, Damiano V, Troiani T, Fontanini G, Raben D, Pepe
S, Bianco AR, Ciardiello F. Enhancement of antitumor
activity of ionizing radiations by combined treatment
with the selective epidermal growth factor receptor-tyrosine
kinase inhibitor ZD1839 (Iressa). Clin Cancer Res 2002;8:3250-8.
Varriale
L, Coppola E, Quarto M, Veneziani BM, Palumbo G. Molecular
aspects of photodynamic therapy: low energy pre-sensitization
of hypericin-loaded human endometrial carcinoma cells
enhances photo-tolerance, alters gene expression and
affects the cell cycle. FEBS Lett 2002;512:287-90.
Veneziani
BM, Di Marino C, Salvatore P, Villone G, Perrotti N,
Frunzio R, Tramontano D. Transfected insulin-like growth
factor II modulates the mitogenic response of rat thyrocites
in culture. Mol Cell Endocrinol 1992;86:11-20.
Veneziani BM, Villone G, Romano R, Di Carlo A, Garbi
C, Tramontano D. The tissue-specific pathway regulating
cell proliferation are inherited independently in somatic
hybrids between thyroid and liver cells. J Cell Biol
1990;111:275-89.
|